RE:RE:RE:RE:Holding 0.35. Pandora wrote: 2b7f6fab wrote: Beano349 wrote: 0.25, my by on the typo
I don't see any expiring soon. Footnote 9 to the financials shows the warrants and when they expire. In June 30, 2023 and September 7, 2023 there were .35 two year warrants issued. And November 29, 2023 .28 five year warrants issued.
TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”). On closing, the Corporation issued an aggregate of 1,000,000 Units at a price of .25 per Unit for aggregate gross proceeds of approximately $250,000.
Each Unit consisted of one common share of the Company (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of .35 per share for a period of 24 months following the date of issuance.
Would that put these warrants ready to expire on Nov. 17, 2024? I did not see an extension but I could be wrong on that.
There was a batch from September 22, 2022 expiring on expiring on September 22, 2024 but they were extended to September 22, 2027.
Yes I do see those warrants on the schedule from the 1st Q, 2024 footnotes. Just over a million warrants @ 35 cents. I suspect they will be extended for 3 more years. Below is the schedule, not sure how it will format correctly or not when this posts. Highlighted in blue with 0.63 at the end indicating the remaining life from 3/31/2024 which is 7.5 months from 3/31/2024. I removed the other warrants that expired back in August and have not added the warrants recently issued the past 7 months.
The following table summarizes information on the common share purchase warrants outstanding
Exercise
Price
Outstanding
Beginning of the
year
Expired During
the period
Exercised
During the
period
Granted During
the period
Outstanding
End of Period
Weighted Average
Remaining Contractual
Life (years)
$0.350 10,058,734 - - - 10,058,734 0.48
$0.350 1,002,700 - - - 1,002,700 0.63 $0.350 4,805,400 - - 4,805,400 1.25
$0.350 1,840,000 - - 1,840,000 1.44
$0.280 5,318,183 - - - 5,318,183 4.66
$0.250 - - - 6,670,836 6,670,836 4.85